Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Sociodemographic differences in parental satisfaction with an autism spectrum disorder diagnosis.

Hidalgo NJ, McINTYRE LL, McWHIRTER EH.

J Intellect Dev Disabil. 2015;40(2):147-155.

PMID:
26213482
2.

Pembrolizumab versus Ipilimumab in Advanced Melanoma.

Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A; KEYNOTE-006 investigators.

N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19.

PMID:
25891173
3.

Cross-sectional investigation of HEMS activities in Europe: a feasibility study.

Di Bartolomeo S, Gava P, Truhlář A, Sandberg M; Euphorea Group.

ScientificWorldJournal. 2014;2014:201570. doi: 10.1155/2014/201570. Epub 2014 Nov 30.

4.

Measuring help-seeking behaviors: factor structure, reliability, and validity among youth with disabilities.

Pham YK, McWhirter EH, Murray C.

J Adolesc. 2014 Apr;37(3):237-46. doi: 10.1016/j.adolescence.2014.01.002. Epub 2014 Feb 7.

PMID:
24636684
5.

Phase II trial of vorinostat in advanced melanoma.

Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A.

Invest New Drugs. 2014 Jun;32(3):526-34. doi: 10.1007/s10637-014-0066-9. Epub 2014 Jan 25.

PMID:
24464266
6.

Peer Associations and Coping: The Mediating Role of Ethnic Identity for Urban, African American Adolescents.

Joyce JA, O'Neil ME, Stormshak EA, McWhirter EH, Dishion TJ.

J Black Psychol. 2013 Oct 1;39(5). doi: 10.1177/0095798412454681.

7.

¿Y ahora qué? Anticipated immigration status barriers and Latina/o high school students' future expectations.

McWhirter EH, Ramos K, Medina C.

Cultur Divers Ethnic Minor Psychol. 2013 Jul;19(3):288-97. doi: 10.1037/a0031814. Epub 2013 Jun 3.

PMID:
23731230
8.

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).

Richter S, Bedard PL, Chen EX, Clarke BA, Tran B, Hotte SJ, Stathis A, Hirte HW, Razak AR, Reedijk M, Chen Z, Cohen B, Zhang WJ, Wang L, Ivy SP, Moore MJ, Oza AM, Siu LL, McWhirter E.

Invest New Drugs. 2014 Apr;32(2):243-9. doi: 10.1007/s10637-013-9965-4. Epub 2013 May 5.

9.

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.

Wolpin BM, O'Reilly EM, Ko YJ, Blaszkowsky LS, Rarick M, Rocha-Lima CM, Ritch P, Chan E, Spratlin J, Macarulla T, McWhirter E, Pezet D, Lichinitser M, Roman L, Hartford A, Morrison K, Jackson L, Vincent M, Reyno L, Hidalgo M.

Ann Oncol. 2013 Jul;24(7):1792-801. doi: 10.1093/annonc/mdt066. Epub 2013 Feb 28.

10.

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group.

N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.

11.

A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium.

Mackay HJ, Au HJ, McWhirter E, Alcindor T, Jarvi A, MacAlpine K, Wang L, Wright JJ, Oza AM.

Invest New Drugs. 2012 Jun;30(3):1158-63. doi: 10.1007/s10637-011-9650-4. Epub 2011 Mar 12.

PMID:
21400081
12.

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.

Sridhar SS, Winquist E, Eisen A, Hotte SJ, McWhirter E, Tannock IF, Mukherjee SD, Wang L, Blattler C, Wright JJ, Moore MJ.

Invest New Drugs. 2011 Oct;29(5):1045-9. doi: 10.1007/s10637-010-9408-4. Epub 2010 Feb 27.

PMID:
20191303
13.

The besieged ward manager: can we afford to continue to ignore the role?

McWhirter E, Scholes J.

Nurs Crit Care. 2009 Mar-Apr;14(2):47-50. doi: 10.1111/j.1478-5153.2009.00321.x. No abstract available.

PMID:
19243520
14.

Baseline radiological staging in primary breast cancer: impact of educational interventions on adherence to published guidelines.

McWhirter E, Yogendran G, Wright F, Pharm GD, Clemons M; Cancer Care Ontario Practice Guidelines Initiative.

J Eval Clin Pract. 2007 Aug;13(4):647-50.

PMID:
17683309
15.

Divergent signal transduction responses to infection with attaching and effacing Escherichia coli.

Ismaili A, McWhirter E, Handelsman MY, Brunton JL, Sherman PM.

Infect Immun. 1998 Apr;66(4):1688-96.

16.

Book reviewing.

HUBBLE D, BAILEY H, McWHIRTER EA.

Br Med J. 1946 Aug 3;2:173. No abstract available.

PMID:
20993845
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk